drugset / Trial / NCT04292691

High Ankle Block in Ankle Fractures

NCT04292691 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of the herein presented double-blinded is to compare the effectiveness of the high foot block against placebo infiltration in simple, uni- and bimalleolar ankle fractures. Included will be all adult patients (\>18a) treated surgically at our department. The standard peri-operative procedure at our clinic will no be altered but the additional high ankle block. The intraoperative opioid requirement, the Visual Analogue Scale for Pain (VAS) and the postoperative opioid requirement will be assessed and compared between the two groups

Timeline

Start
2020-04-01
Primary completion
2021-04-01
Completion
2021-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ropivacaine Other / unclassified 400 mg —

Indications

No indication recorded.